Schedule 13G ownership disclosure
Ampio Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 03209T109
Event date: 2016-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,877,886
- Percent of class
- 4.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-17-008038
- Form type
- SC 13G
- Filer
- Ampio Pharmaceuticals, Inc.
- CIK
- CIK 1411906
- Filed
- Feb 10, 2017
- Reporting period
- Dec 31, 2016
- Description
- Schedule 13G beneficial ownership